美股市场个股详情

AQST Aquestive Therapeutics

添加自选

2.780
-0.160-5.44%

交易中 03/13 14:19 (美东)

2.75亿总市值-5.45市盈率TTM

关于Aquestive Therapeutics公司

aququestive Therapeutics, Inc.从事识别、开发和商业化差异化产品，以解决未满足的医疗需求并解决患者的治疗问题。其产品线包括Libervant、AQST-108、AQST-305、Suboxone和Zuplenz。

公司介绍

公司代码AQST

公司名称Aquestive Therapeutics

上市日期2018/07/25

发行价格15.00

成立日期2004

CEOMr. Daniel Barber

所属市场纳斯达克

员工数量142

年结日12-31

公司地址30 Technology Drive

城市Warren

省份新泽西

国家美国

邮编07059

电话1-908-941-1900

网址http://www.aquestive.com

董事高管

姓名
职务
年薪

Daniel Barber
Chief Executive Officer, President and Director
249.61万

Cassie Jung
Chief Operating Officer
--

Lori J. Braender
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
119.40万

Dr. Carl N. Kraus, M.D.
Chief Medical Officer
--

A. Ernest Toth, Jr
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
111.59万

A. Mark Schobel
Chief Innovation and Technology Officer
--

Stephen Wargacki
Chief Science Officer
--

Peter Boyd
Senior Vice President, Information Technology, Human Resources and Communications
--

John S. Cochran
Vice Chairman of the Board
13.72万

Dr. Gregory B. Brown,M.D.
Chairman of the Board
15.08万

Dr. Julie Krop, M.D.
Independent Director
13.77万

Dr. Marco Taglietti,M.D.
Independent Director
12.18万

Abigail L. Jenkins, B.A.,M.S.
Independent Director
--

Timothy E. Morris
Independent Director
14.52万